There’s good news in 2026 for seniors enrolled in Medicare Part D who rely on the priciest prescription drugs: 10 high-cost ...

The price hikes come even as the Trump administration pressures pharmaceutical companies to lower costs for patients and ...

Medicare's cap on out-of-pocket costs helps cancer patients and others taking expensive drugs. With less financial burden, ...

Changes are coming in 2026 for GLP-1 drugs. Long defined by high prices, shortages and weekly injections, drugs including ...

Medicare beneficiaries could see out-of-pocket prescription drug costs cut by more than half in 2026, according to a new AARP ...

Several common drugs will be cheaper next year under Medicare, from weight-loss drug Ozempic to breast-cancer medication Ibrance, according to the Centers for Medicare & Medicaid Services (CMS).

Drug prices skyrocket in 2026 as drugmakers plan hikes on 350 medications, despite Trump administration affordability pledges ...

Pennsylvanians will see their out-of-pocket costs for 10 medications drop by 53% on average, according to a new AARP report.

The cost of prescription drugs is soaring. A new report shows, even during the pandemic, consumers have had to pay three times more for some of their medicines. The latest RX Price Watch Report from ...

States increasingly struggling to cover the rising cost of popular GLP-1 drugs like Wegovy, Ozempic and Zepbound are searching for ways to get out from under the budgetary squeeze that took them by ...

Tirzepatide can cost $500 to $1,900 a month without insurance. More affordable tirzepatide alternatives include semaglutide, ...

As the expiration date on Alexion Pharmaceuticals' patent protections grew closer and competitors began developing their own ...